Open access · OA
via OpenAlex
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Ali Golchin, Ehsan Seyedjafari, Abdolreza Ardeshirylajimi
Stem Cell Reviews and Reports · 2020 · ▲ 332 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s12015-020-09973-w
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Golchin, A., Seyedjafari, E., & Ardeshirylajimi, A. (2020). Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. <em>Stem Cell Reviews and Reports</em>. https://doi.org/10.1007/s12015-020-09973-w
Vancouver
Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. Stem Cell Reviews and Reports. 2020. doi:10.1007/s12015-020-09973-w.
BibTeX
@article{ali2020Mesenc,
title = {Mesenchymal Stem Cell Therapy for COVID-19: Present or Future},
author = {Ali Golchin and Ehsan Seyedjafari and Abdolreza Ardeshirylajimi},
journal = {Stem Cell Reviews and Reports},
year = {2020},
doi = {10.1007/s12015-020-09973-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Orthopaedics and Trauma 2016
Open access · OA
Mesenchymal stem cell therapy for osteoarthritis
Stem cells in clinical applications 2016
Citation only
Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis
Aesthetic Plastic Surgery 2009
Open access · OA
Adipose-Derived Mesenchymal Stem Cells: Past, Present, and Future
Experimental Gerontology 2005
Citation only
Mesenchymal stem cell aging
Cytotherapy 2021
Citation only
Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease
Springer eBooks 2017
Citation only